EP. 1: New Diagnosis of Schizophrenia Initiated on Long-Acting InjectableByBryce Reynolds, MD,Hannah Phillips-Hall, MSN, PMHNP-BCDecember 2nd 2020
EP. 2: Transitioning to Long-Acting Injectables in SchizophreniaByBryce Reynolds, MD,Hannah Phillips-Hall, MSN, PMHNP-BCDecember 2nd 2020
EP. 3: The Benefits of Long-Acting Injectables for SchizophreniaByBryce Reynolds, MD,Hannah Phillips-Hall, MSN, PMHNP-BCDecember 2nd 2020
EP. 4: Challenges and Unmet Needs When Treating Schizophrenia ByBryce Reynolds, MD,Hannah Phillips-Hall, MSN, PMHNP-BCDecember 2nd 2020
EP. 5: APA Guidelines for the Treatment of Schizophrenia With LAIsByBryce Reynolds, MD,Hannah Phillips-Hall, MSN, PMHNP-BCDecember 2nd 2020
EP. 6: Frequency of Long-Acting Injectable Agents for SchizophreniaByBryce Reynolds, MD,Hannah Phillips-Hall, MSN, PMHNP-BCDecember 2nd 2020
EP. 7: Motivating Patients With Schizophrenia to Initiate an LAIByBryce Reynolds, MD,Hannah Phillips-Hall, MSN, PMHNP-BCDecember 2nd 2020
EP. 8: Advice for Treating Schizophrenia During COVID-19ByBryce Reynolds, MD,Hannah Phillips-Hall, MSN, PMHNP-BCDecember 2nd 2020